CYRX

Cryoport Inc

Industrials · USD

CYRX

Price

$9.67

-0.92%

Cap

$482M

Earnings

3/4 beat

30d Trend

-1%

CYRX
Loading chart data...
0 days · % change from startPowered by Brain47
52-week range71%
5.2111.45

Upper half of range — momentum is positive

Analyst consensus (10 analysts)+41% to target
7 Strong Buy1 Buy2 Hold0 Sell0 Strong Sell

Target range: $9.5$16 (consensus: $13.61)

Consensus: Strong Buy

Earnings history

Q4 2025

BEAT

-0.17 vs -0.2

Q3 2025

BEAT

-0.18 vs -0.22

Q2 2025

BEAT

2.05 vs -0.27

Q1 2025

MISS

-0.28 vs -0.27

VolatilityLow

Key macro factors

·

Rising Inflation and 'Higher for Longer' Interest Rates: Elevated inflation and sustained high interest rates can increase CryoPort's operating costs (e.g., fuel, labor, capital) and potentially constrain investment within the broader life sciences sector, impacting demand for specialized logistics.

·

Geopolitical Volatility and Global Supply Chain Disruptions: CryoPort's operations are global, making it susceptible to disruptions from geopolitical events, such as the Strait of Hormuz closure. Such events can lead to increased shipping costs, delays, and complexities in its temperature-controlled logistics.

·

Funding Environment for Life Sciences Startups: A slowdown or decline in funding for cell and gene therapy startups and clinical trials, which are key clients for CryoPort, could temper future growth in demand for its specialized supply chain solutions and services.

CryoPort Inc is a leading global provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, focusing on supporting the cell and gene therapy market with services including logistics, biostorage, and cryogenic systems manufacturing.

Next earnings:2026-05-06

QUANT SCORE

Building intelligence for this stock. Brain47 needs a few days of price data to calculate technical indicators and generate a full quant score.

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.

Cryoport Inc (CYRX) — Brain47 AI Score 62/100 | Analysis